News Sinopharm Group Co. Ltd.

Stocks

1099

CNE100000FN7

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:36 10/07/2026 pm IST			5-day change	1st Jan Change
16.73 ^HKD	+0.42%		-0.06%	-13.94%

18/06	Sinopharm Group Co. Ltd. Approves Ordinary Final Dividend for the Year Ended 31 December 2025, Payable on 18 August 2026	CI
27/04	Earnings Season, Tehran Proposal Lift Asian Stock Markets	MT

All News

Mentions Relevance

18/06	Sinopharm Group Co. Ltd. Approves Ordinary Final Dividend for the Year Ended 31 December 2025, Payable on 18 August 2026	CI
27/04	Sinopharm Group Records Drop in Q1 2026 Profit	MT
27/04	Sinopharm Group posts qtrly total operating revenue RMB 140.77 billion	RE
23/04	Sinopharm Arm's Operating Profit Slips 20% in Q1	MT
21/04	Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
21/04	China National Accord Medicines' Q1 Profit Slips 12%	MT
24/03	Nomura Adjusts Sinopharm Group's Price Target to HK$24.23 From HK$23.40, Keeps at Buy	MT
23/03	Sinopharm's Profit Rises Slightly Despite Revenue Dip in 2025	MT
23/03	Sinopharm : 2025 Annual Results Presentation	PU
23/03	Sinopharm Group posts FY profit attributable of RMB7.16 bln	RE
23/03	Sinopharm Group Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
23/03	Sinopharm Group Co. Ltd. Proposes Final Dividend for the Year Ended 31 December 2025, Payable No Later Than 18 August 2026	CI
18/03	China National Accord Medicines' Profit Jumps 77% in 2025	MT
28/11	Sinopharm Group Co. Ltd. Announces Board and Committee Resignations	CI
28/11	Sinopharm says Zhao Bingxiang resigns as chairman	RE
26/11	JPMorgan Chase & Co's short position in H-shares of Sinopharm Group decreased to 1.45% on Nov 21 - HKEX	RE
06/11	Sinopharm Group Co. Ltd. Announces Resignation of Sun Jinglin as an Executive Director and A Member of the Strategy and Investment Committee of the Board	CI
28/25/28	UOB Kay Hian Upgrades Sinopharm Group to Hold from Sell; Price Target is HK$20	MT
27/25/27	Sinopharm Group's Nine-Month Profit Rises Despite Revenue Drop	MT
27/25/27	Sinopharm Group posts 9M net profit attributable RMB5.31 billion	RE
21/25/21	China National Accord Medicines' Q3 Profit Slumps 10%	MT
21/25/21	Sinopharm Group Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
17/25/17	Bristol Myers Squibb Exits China JV	MT
25/25/25	Sinopharm Group Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25/25/25	Sinopharm : 2025 Interim Results Presentation	PU